Income Statement Celltrion, Inc.

Stocks

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 10/06/2026			5-day change	1st Jan Change
1,67,300.00 ^KRW	-1.59%		-6.51%	-2.95%

02/06	Celltrion Workers Form Labor Union	MT
21/05	Celltrion, Inc. authorizes a Buyback Plan.	CI

65.4Tm_Yn2LhapA60C7UMH_lKgaxMZIajclmQMNhkoBd98.jHj4EwfO79I2hzGNFrTMoeVgsYB5B0Fo_VtK3n45QKiUe84RO-7IyxmYJw

Published financial data: CELLTRION, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1,91200Cr	2,28400Cr	2,17600Cr	3,55700Cr	4,16200Cr
Other Revenues, Total	-30	-10	-10	-10	-10
Total Revenues	1,91200Cr	2,28400Cr	2,17600Cr	3,55700Cr	4,16200Cr
Cost of Goods Sold, Total	81TCr	1,25100Cr	1,12500Cr	1,87600Cr	1,69500Cr
Gross Profit	1,10600Cr	1,03300Cr	1,05200Cr	1,68200Cr	2,46700Cr
Selling General & Admin Expenses, Total	19TCr	20TCr	20TCr	75TCr	92TCr
Provision for Bad Debts	1.43Cr	-16.86L	-503.3Cr	102.75Cr	710.99Cr
R&D Expenses	13TCr	14TCr	16TCr	20TCr	21TCr
Depreciation & Amortization - (IS)	279.54Cr	346.02Cr	535.17Cr	1.29TCr	1.72TCr
Amortization of Goodwill and Intangible Assets - (IS)	3.43TCr	3.74TCr	3.56TCr	16TCr	5.1TCr
Other Operating Expenses	-	-	-	6.49TCr	9.33TCr
Other Operating Expenses, Total	35TCr	39TCr	40TCr	1,19000Cr	1,30200Cr
Operating Income	76TCr	65TCr	65TCr	49TCr	1,16500Cr
Interest Expense, Total	-823.76Cr	-750.75Cr	-966.53Cr	-7.56TCr	-7.55TCr
Interest And Investment Income	439.62Cr	1.42TCr	1.91TCr	3.35TCr	2.32TCr
Net Interest Expenses	-384.15Cr	671.08Cr	939.84Cr	-4.2TCr	-5.23TCr
Income (Loss) On Equity Invest.	-497.25Cr	734.74Cr	-1.27TCr	-342.93Cr	-1.67TCr
Currency Exchange Gains (Loss)	3.29TCr	1.7TCr	1.16TCr	14TCr	18TCr
Other Non Operating Income (Expenses)	-631.36Cr	-4.14TCr	35Cr	-153.82Cr	-12TCr
EBT, Excl. Unusual Items	77TCr	64TCr	66TCr	59TCr	1,15400Cr
Gain (Loss) On Sale Of Investments	115.16Cr	-	150.88Cr	8.05Cr	-
Gain (Loss) On Sale Of Assets	3.29TCr	83Cr	1.33TCr	406.56Cr	9.06Cr
Asset Writedown	-5.74TCr	-1.15TCr	-388.39Cr	-1.69TCr	-61Cr
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	75TCr	63TCr	67TCr	58TCr	1,15400Cr
Income Tax Expense	16TCr	9.48TCr	13TCr	16TCr	12TCr
Earnings From Continuing Operations	60TCr	53TCr	54TCr	42TCr	1,03100Cr
Earnings Of Discontinued Operations	-	1.12TCr	-	-	-
Net Income to Company	60TCr	54TCr	54TCr	42TCr	1,03100Cr
Minority Interest	-1.63TCr	-473.07Cr	-405.85Cr	380.84Cr	-187.04Cr
Net Income - (IS)	58TCr	54TCr	54TCr	42TCr	1,03000Cr
Net Income to Common Incl Extra Items	58TCr	54TCr	54TCr	42TCr	1,03000Cr
Net Income to Common Excl. Extra Items	58TCr	53TCr	54TCr	42TCr	1,03000Cr
Per Share Items
Net EPS - Basic	3.49T	3.27T	3.28T	1.79T	4.45T
Basic EPS - Continuing Operations	3.49T	3.2T	3.28T	1.79T	4.45T
Basic Weighted Average Shares Outstanding	17Cr	16Cr	16Cr	24Cr	23Cr
Net EPS - Diluted	3.45T	3.26T	3.27T	1.78T	4.44T
Diluted EPS - Continuing Operations	3.45T	3.19T	3.27T	1.78T	4.44T
Diluted Weighted Average Shares Outstanding	17Cr	16Cr	16Cr	24Cr	23Cr
Normalized Basic EPS	2.82T	2.39T	2.5T	1.57T	3.11T
Normalized Diluted EPS	2.8T	2.38T	2.5T	1.57T	3.1T
Dividend Per Share	616.62	314.47	436.07	654.11	714.29
Payout Ratio	0	19.05	9.64	24.51	14.93
Supplemental Items
EBITDA	97TCr	87TCr	90TCr	91TCr	1,45200Cr
EBITA	91TCr	81TCr	83TCr	84TCr	1,35900Cr
EBIT	76TCr	65TCr	65TCr	49TCr	1,16500Cr
EBITDAR	97TCr	87TCr	90TCr	-	-
Effective Tax Rate - (Ratio)	20.7	15.14	19.58	27.29	10.59
Normalized Net Income	47TCr	39TCr	41TCr	37TCr	72TCr
Interest Capitalized	812.51Cr	1.64TCr	3.26TCr	2.07TCr	-
Supplemental Operating Expense Items
Advertising Expense	1.28TCr	1.51TCr	1.73TCr	9.36TCr	12TCr
Selling and Marketing Expenses	5.34TCr	5.97TCr	7.69TCr	38TCr	47TCr
General and Administrative Expenses	2.28TCr	330.34Cr	723.45Cr	892.86Cr	1.19TCr
Research And Development Expense From Footnotes	13TCr	14TCr	16TCr	20TCr	21TCr
Net Rental Expense, Total	34Cr	35Cr	37Cr	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	946.08Cr	1.12TCr	1.2TCr	2.68TCr	2.3TCr
Total Stock-Based Compensation	946.08Cr	1.12TCr	1.2TCr	2.68TCr	2.3TCr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1,18800Cr	55TCr	56TCr	1LCr	1,11900Cr
Short Term Investments	3.16TCr	4.33TCr	19TCr	15TCr	12TCr
Trading Asset Securities, Total	-	-	-	-	236.88Cr
Total Cash And Short Term Investments	1,22000Cr	59TCr	76TCr	1,14300Cr	1,23900Cr
Accounts Receivable, Total	1,10100Cr	1,62200Cr	94TCr	1,21500Cr	1,79000Cr
Other Receivables	2.08TCr	1.31TCr	881.7Cr	4.37TCr	4.93TCr
Notes Receivable	4.25TCr	1.91TCr	125Cr	113.41Cr	175Cr
Total Receivables	1,16400Cr	1,65400Cr	95TCr	1,26000Cr	1,84100Cr
Inventory	58TCr	62TCr	3,04100Cr	2,76600Cr	2,80300Cr
Prepaid Expenses	1.13TCr	1.34TCr	1.78TCr	2.51TCr	3.93TCr
Other Current Assets, Total	10TCr	5.15TCr	11TCr	39TCr	28TCr
Total Current Assets	3,07400Cr	2,93000Cr	4,88100Cr	5,58400Cr	6,20500Cr
Gross Property Plant And Equipment	1,42300Cr	1,54400Cr	1,81600Cr	1,71000Cr	2,46200Cr
Accumulated Depreciation	-47TCr	-54TCr	-60TCr	-47TCr	-76TCr
Net Property Plant And Equipment	95TCr	1,00700Cr	1,21500Cr	1,24500Cr	1,70300Cr
Long-term Investments	8.93TCr	12TCr	14TCr	16TCr	17TCr
Goodwill	3.3TCr	3.52TCr	11,47500Cr	11,91400Cr	11,87800Cr
Other Intangibles, Total	29TCr	26TCr	50TCr	39TCr	37TCr
Accounts Receivable Long-Term	0	6.29TCr	0	0	1.63TCr
Loans Receivable Long-Term	0	13Cr	13Cr	25Cr	28Cr
Deferred Tax Assets Long-Term	2.86TCr	3.22TCr	6.35TCr	19TCr	29TCr
Deferred Charges Long-Term	1,17200Cr	1,32200Cr	1,35800Cr	1,39800Cr	1,52700Cr
Other Long-Term Assets, Total	3.98TCr	12TCr	29TCr	17TCr	17TCr
Total Assets	5,67400Cr	5,89200Cr	19,91800Cr	21,05500Cr	22,33500Cr
Liabilities
Accounts Payable, Total	8.07TCr	5.03TCr	5.09TCr	7.53TCr	12TCr
Accrued Expenses, Total	14TCr	16TCr	19TCr	15TCr	19TCr
Short-term Borrowings	51TCr	55TCr	1,60800Cr	1,98900Cr	3,24000Cr
Current Portion of Long-Term Debt	5.45TCr	8.14TCr	17TCr	8.62TCr	6.35TCr
Current Portion of Leases	300.99Cr	272.82Cr	817.06Cr	1.17TCr	1.35TCr
Current Income Taxes Payable	18TCr	8.87TCr	5.7TCr	22TCr	2.81TCr
Unearned Revenue Current, Total	357.53Cr	676.89Cr	2.17TCr	1.82TCr	1.58TCr
Other Current Liabilities	24TCr	35TCr	37TCr	64TCr	78TCr
Total Current Liabilities	1,21000Cr	1,29400Cr	2,47100Cr	3,18700Cr	4,45400Cr
Long-Term Debt	17TCr	15TCr	9.91TCr	8.66TCr	39TCr
Long-Term Leases	437.43Cr	288.79Cr	798.26Cr	1.91TCr	2.51TCr
Unearned Revenue Non Current	2.82TCr	2.3TCr	7.74TCr	7.35TCr	4.7TCr
Pension & Other Post Retirement Benefits	-	335.45Cr	-	-	-
Deferred Tax Liability Non Current	2.16TCr	110.5Cr	12TCr	9.93TCr	5.68TCr
Other Non Current Liabilities	19TCr	14TCr	1.71TCr	960.4Cr	1.25TCr
Total Liabilities	1,62400Cr	1,61700Cr	2,79200Cr	3,47500Cr	4,98200Cr
Common Stock, Total	14TCr	14TCr	22TCr	22TCr	24TCr
Additional Paid In Capital	86TCr	87TCr	14,79000Cr	14,82800Cr	14,21500Cr
Retained Earnings	3,05200Cr	3,48500Cr	3,96400Cr	3,74400Cr	4,40700Cr
Treasury Stock	-23TCr	-50TCr	-2,20400Cr	-2,10800Cr	-2,18600Cr
Comprehensive Income and Other	9.62TCr	14TCr	21TCr	75TCr	53TCr
Total Common Equity	3,91700Cr	4,13900Cr	16,98100Cr	17,43900Cr	17,20800Cr
Minority Interest	13TCr	13TCr	15TCr	14TCr	14TCr
Total Equity	4,05000Cr	4,27400Cr	17,12600Cr	17,58000Cr	17,35300Cr
Total Liabilities And Equity	5,67400Cr	5,89200Cr	19,91800Cr	21,05500Cr	22,33500Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	17Cr	16Cr	24Cr	24Cr	23Cr
ECS Total Common Shares Outstanding	17Cr	16Cr	24Cr	24Cr	23Cr
Book Value / Share	23.57T	25.19T	71.47T	74.19T	74.97T
Tangible Book Value	3,59800Cr	3,83900Cr	5,00300Cr	5,13500Cr	4,95700Cr
Tangible Book Value Per Share	21.65T	23.37T	21.06T	21.85T	21.59T
Total Debt	74TCr	79TCr	1,89000Cr	2,19300Cr	3,72900Cr
Net Debt	-48TCr	20TCr	1,13300Cr	1,05000Cr	2,49000Cr
Debt Equivalent Oper. Leases	269.29Cr	276.3Cr	295.77Cr	-	-
Minority Interest, Total (Incl. Fin. Div)	13TCr	13TCr	15TCr	14TCr	14TCr
Equity Method Investments, Total	6.48TCr	8.85TCr	10TCr	11TCr	11TCr
Inventories - Raw Materials, Total	24TCr	30TCr	28TCr	33TCr	52TCr
Inventories - Work In Process, Total	3.97TCr	4.83TCr	7.86TCr	10TCr	8.81TCr
Inventories - Finished Goods, Total	36TCr	37TCr	2,72700Cr	2,38600Cr	2,22900Cr
Inventories - Others	219.85Cr	1.15TCr	1.02TCr	1.34TCr	940.32Cr
Land - (BS)	30TCr	30TCr	30TCr	30TCr	32TCr
Buildings, Total	37TCr	37TCr	60TCr	60TCr	80TCr
Machinery, Total	68TCr	70TCr	72TCr	72TCr	1,12700Cr
Accumulated Allowance for Doubtful Accounts (Supple)	135.88Cr	153.35Cr	31Cr	248.09Cr	566.55Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	58TCr	54TCr	54TCr	42TCr	1,03000Cr
Depreciation & Amortization - CF	6.2TCr	6.47TCr	6.38TCr	7.26TCr	9.28TCr
Amortization of Goodwill and Intangible Assets - (CF)	15TCr	16TCr	18TCr	35TCr	19TCr
Depreciation & Amortization, Total	21TCr	23TCr	25TCr	42TCr	29TCr
(Gain) Loss From Sale Of Asset	-2.39TCr	88Cr	-196.11Cr	-4.42TCr	-9.06Cr
(Gain) Loss on Sale of Investments - (CF)	-999.83Cr	-84Cr	-1.28TCr	5.68TCr	615.03Cr
Asset Writedown & Restructuring Costs	5.72TCr	1.06TCr	382.28Cr	15Cr	61Cr
(Income) Loss On Equity Investments - (CF)	497.25Cr	-1.57TCr	1.27TCr	342.93Cr	1.74TCr
Stock-Based Compensation (CF)	2.2TCr	2.57TCr	2.78TCr	4.52TCr	3.87TCr
Provision and Write-off of Bad Debts	-23Cr	751.13Cr	-508.02Cr	102.75Cr	318.45Cr
Other Operating Activities, Total	6.78TCr	-4.34TCr	-4.73TCr	1.98TCr	-24TCr
Change In Accounts Receivable	11TCr	-68TCr	-30TCr	-17TCr	-34TCr
Change In Inventories	-27TCr	-21TCr	5.73TCr	22TCr	-13TCr
Change In Accounts Payable	4.41TCr	5.36TCr	-219.25Cr	-14TCr	-15TCr
Change in Other Net Operating Assets	11TCr	9.62TCr	1.95TCr	7.22TCr	13TCr
Cash from Operations	91TCr	86Cr	54TCr	90TCr	65TCr
Capital Expenditure	-6.34TCr	-11TCr	-21TCr	-14TCr	-11TCr
Sale of Property, Plant, and Equipment	1.34Cr	34.6L	1.15Cr	3.88Cr	2.96Cr
Cash Acquisitions	-	-348.7Cr	37TCr	-2.87TCr	-54TCr
Divestitures	-	1.75TCr	-	-	-
Sale (Purchase) of Intangible assets	-23TCr	-20TCr	-14TCr	-20TCr	-22TCr
Investment in Marketable and Equity Securities, Total	-5.7TCr	-3.94TCr	-19TCr	-3.04TCr	-1.19TCr
Other Investing Activities, Total	-506.51Cr	4.03TCr	2.36TCr	22TCr	1.84TCr
Cash from Investing	-36TCr	-30TCr	-14TCr	-17TCr	-86TCr
Long-Term Debt Issued, Total	21TCr	18TCr	83TCr	2,13700Cr	3,38600Cr
Total Debt Issued	21TCr	18TCr	83TCr	2,13700Cr	3,38600Cr
Long-Term Debt Repaid, Total	-24TCr	-14TCr	-21TCr	-1,89100Cr	-1,91300Cr
Total Debt Repaid	-24TCr	-14TCr	-21TCr	-1,89100Cr	-1,91300Cr
Issuance of Common Stock	2.15TCr	986.22Cr	735.88Cr	2.11TCr	1.19TCr
Repurchase of Common Stock	-3.91TCr	-28TCr	-92TCr	-44TCr	-91TCr
Common & Preferred Stock Dividends Paid	-37.81L	-10TCr	-5.17TCr	-10TCr	-15TCr
Common & Preferred Stock Dividends Paid	-37.81L	-10TCr	-5.17TCr	-10TCr	-15TCr
Other Financing Activities, Total	-1.6TCr	-2.27TCr	-4.39TCr	-7.77TCr	-8.42TCr
Cash from Financing	-6.93TCr	-35TCr	-39TCr	-35TCr	34TCr
Foreign Exchange Rate Adjustments	1.8TCr	926.79Cr	25Cr	5.24TCr	-217.47Cr
Miscellaneous Cash Flow Adjustments	-	-	-	-	-130
Net Change in Cash	50TCr	-64TCr	1.34TCr	43TCr	12TCr
Supplemental Items
Cash Interest Paid	1.6TCr	2.27TCr	4.18TCr	7.52TCr	8.28TCr
Cash Income Tax Paid (Refund)	14TCr	22TCr	15TCr	14TCr	44TCr
Levered Free Cash Flow	52TCr	-14TCr	-1,44900Cr	51TCr	17TCr
Unlevered Free Cash Flow	52TCr	-14TCr	-1,44300Cr	56TCr	22TCr
Change In Net Working Capital	-12TCr	47TCr	1,75700Cr	-14TCr	49TCr
Net Debt Issued / Repaid	-3.56TCr	4.56TCr	62TCr	25TCr	1,47400Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.85	6.99	3.16	1.5	3.35
Return on Total Capital	10.52	8.2	3.38	1.59	3.56
Return On Equity %	15.93	12.77	5.04	2.41	5.91
Return on Common Equity	16.04	13.07	5.07	2.46	5.94
Margin Analysis
Gross Profit Margin %	57.85	45.22	48.33	47.27	59.27
SG&A Margin	9.74	8.97	9.34	21.08	22.18
EBITDA Margin %	50.8	38.25	41.23	25.59	34.88
EBITA Margin %	47.55	35.41	38.3	23.55	32.66
EBIT Margin %	39.59	28.34	29.93	13.83	27.98
Income From Continuing Operations Margin %	31.17	23.26	24.8	11.78	24.78
Net Income Margin %	30.31	23.55	24.61	11.88	24.74
Net Avail. For Common Margin %	30.31	23.06	24.61	11.88	24.74
Normalized Net Income Margin	24.47	17.22	18.77	10.45	17.29
Levered Free Cash Flow Margin	27.04	-6.13	-66.58	14.42	4.13
Unlevered Free Cash Flow Margin	27.31	-5.92	-66.31	15.75	5.26
Asset Turnover
Asset Turnover	0.36	0.39	0.17	0.17	0.19
Fixed Assets Turnover	2.02	2.33	1.96	2.89	2.82
Receivables Turnover (Average Receivables)	1.62	1.68	1.7	3.3	2.77
Inventory Turnover (Average Inventory)	1.67	2.1	0.61	0.65	0.61
Short Term Liquidity
Current Ratio	2.54	2.26	1.98	1.75	1.39
Quick Ratio	1.93	1.72	0.69	0.75	0.69
Operating Cash Flow to Current Liabilities	0.75	0	0.22	0.28	0.15
Days Sales Outstanding (Average Receivables)	224.69	217.58	214.75	110.83	131.78
Days Outstanding Inventory (Average Inventory)	217.96	174.21	593.61	566.36	599.49
Average Days Payable Outstanding	20.94	18.54	5.2	14.4	21.05
Cash Conversion Cycle (Average Days)	421.71	373.25	803.16	662.78	710.22
Long Term Solvency
Total Debt/Equity	18.38	18.54	11.04	12.47	21.49
Total Debt / Total Capital	15.52	15.64	9.94	11.09	17.69
LT Debt/Equity	4.31	3.61	0.63	0.6	2.38
Long-Term Debt / Total Capital	3.64	3.05	0.56	0.53	1.96
Total Liabilities / Total Assets	28.62	27.45	14.02	16.5	22.31
EBIT / Interest Expense	91.88	86.21	67.4	6.51	15.43
EBITDA / Interest Expense	117.87	116.36	92.83	12.04	19.24
(EBITDA - Capex) / Interest Expense	110.18	101.55	71.1	10.26	17.81
Total Debt / EBITDA	0.77	0.91	2.11	2.41	2.57
Net Debt / EBITDA	-0.49	0.23	1.26	1.15	1.71
Total Debt / (EBITDA - Capex)	0.82	1.04	2.75	2.83	2.77
Net Debt / (EBITDA - Capex)	-0.52	0.26	1.65	1.35	1.85
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.38	20.63	-4.71	63.45	17.01
Gross Profit, 1 Yr. Growth %	7.6	-5.05	1.86	59.88	46.7
EBITDA, 1 Yr. Growth %	8.8	-8.84	2.71	1.45	59.52
EBITA, 1 Yr. Growth %	8.9	-9.76	3.04	0.5	62.27
EBIT, 1 Yr. Growth %	5.32	-13.03	0.65	-24.47	136.69
Earnings From Cont. Operations, 1 Yr. Growth %	13.33	-9.3	1.57	-22.39	146.25
Net Income, 1 Yr. Growth %	11.92	-7.18	-0.41	-21.09	143.58
Normalized Net Income, 1 Yr. Growth %	16.6	-14.48	3.87	-8.97	113.91
Diluted EPS Before Extra, 1 Yr. Growth %	12.42	-6.46	2.6	-45.51	148.4
Accounts Receivable, 1 Yr. Growth %	-12.08	47.3	-42.09	29.4	47.33
Inventory, 1 Yr. Growth %	50.41	6.62	393.46	-8.98	1.36
Net Property, Plant and Equip., 1 Yr. Growth %	0.44	5.96	20.61	2.47	36.8
Total Assets, 1 Yr. Growth %	13.03	3.83	238.06	5.5	6.08
Tangible Book Value, 1 Yr. Growth %	21.15	6.71	30.31	1.72	-3.47
Common Equity, 1 Yr. Growth %	18.43	5.67	310.22	2.7	-1.32
Cash From Operations, 1 Yr. Growth %	159.78	-99.91	62.1T	67.9	-28.37
Capital Expenditures, 1 Yr. Growth %	-27.16	75.4	88.94	-35.7	-19.87
Levered Free Cash Flow, 1 Yr. Growth %	-231.34	-127.5	935.48	-134.39	-66.52
Unlevered Free Cash Flow, 1 Yr. Growth %	-234.25	-126.31	966.93	-137.71	-60.92
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	30.15	11.14	7.21	24.8	38.29
Gross Profit, 2 Yr. CAGR %	32.12	0.24	-1.66	27.61	53.15
EBITDA, 2 Yr. CAGR %	34.69	-1.06	-3.24	2.08	27.21
EBITA, 2 Yr. CAGR %	36.64	-1.56	-3.57	1.76	27.71
EBIT, 2 Yr. CAGR %	40.84	-5.1	-6.44	-12.81	33.7
Earnings From Cont. Operations, 2 Yr. CAGR %	40.59	0.54	-4.02	-11.21	38.25
Net Income, 2 Yr. CAGR %	38.74	1.92	-3.86	-11.35	38.64
Normalized Net Income, 2 Yr. CAGR %	40.5	-0.99	-5.75	-2.76	32.71
Diluted EPS Before Extra, 2 Yr. CAGR %	38.84	2.05	-2.07	-25.23	16.44
Accounts Receivable, 2 Yr. CAGR %	16.28	13.8	-7.64	-13.44	38.07
Inventory, 2 Yr. CAGR %	37.28	26.64	129.38	111.84	-3.95
Net Property, Plant and Equip., 2 Yr. CAGR %	1.44	3.16	13.05	11.17	18.4
Total Assets, 2 Yr. CAGR %	21.25	8.33	87.36	89.04	5.79
Tangible Book Value, 2 Yr. CAGR %	15.19	13.7	17.92	15.66	-0.91
Common Equity, 2 Yr. CAGR %	19.13	11.87	108.2	105.26	0.67
Cash From Operations, 2 Yr. CAGR %	38.65	-95.04	-23.22	3.13T	9.67
Capital Expenditures, 2 Yr. CAGR %	-18.01	13.03	82.05	10.22	-28.22
Levered Free Cash Flow, 2 Yr. CAGR %	105.31	-40.37	68.73	91.47	-66.07
Unlevered Free Cash Flow, 2 Yr. CAGR %	100.86	-41.02	67.54	103.53	-61.61
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	24.86	26.49	5.58	23.39	22.15
Gross Profit, 3 Yr. CAGR %	26.14	17.69	0.78	15.64	33.68
EBITDA, 3 Yr. CAGR %	29.46	17.74	0.18	-1.7	18.46
EBITA, 3 Yr. CAGR %	30.77	18.43	-0.05	-2.23	18.89
EBIT, 3 Yr. CAGR %	32.86	19.26	-3.22	-12.88	21.63
Earnings From Cont. Operations, 3 Yr. CAGR %	35.88	20.8	0.88	-10.58	24.75
Net Income, 3 Yr. CAGR %	33.1	21.34	1.14	-9.98	24.17
Normalized Net Income, 3 Yr. CAGR %	33.33	18.39	0.6	-6.84	22.31
Diluted EPS Before Extra, 3 Yr. CAGR %	32.45	21.32	2.21	-19.45	11.63
Accounts Receivable, 3 Yr. CAGR %	10.88	25.82	-9.15	3.34	3.35
Inventory, 3 Yr. CAGR %	52.52	26.19	99.28	68.51	65.69
Net Property, Plant and Equip., 3 Yr. CAGR %	2.54	2.93	8.68	9.4	19.13
Total Assets, 3 Yr. CAGR %	17.44	15.14	58.31	54.82	55.92
Tangible Book Value, 3 Yr. CAGR %	13.54	12.29	18.99	12.59	8.89
Common Equity, 3 Yr. CAGR %	16.36	14.46	72.51	64.51	60.79
Cash From Operations, 3 Yr. CAGR %	35.68	-87.79	15.27	-0.34	807.81
Capital Expenditures, 3 Yr. CAGR %	-7.25	5.65	34.15	28.68	-0.89
Levered Free Cash Flow, 3 Yr. CAGR %	61.06	4.5	54.42	0.27	7.07
Unlevered Free Cash Flow, 3 Yr. CAGR %	57.77	1.49	54.82	2.91	17.42
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	23.31	19.2	17.25	25.81	17.62
Gross Profit, 5 Yr. CAGR %	23.13	8.15	13.81	21.56	19.14
EBITDA, 5 Yr. CAGR %	25.98	7.89	14.92	11.2	10.23
EBITA, 5 Yr. CAGR %	28.1	7.79	15.44	11.46	10.24
EBIT, 5 Yr. CAGR %	27.9	5.32	15.08	5.22	10.14
Earnings From Cont. Operations, 5 Yr. CAGR %	31.87	7.06	17.84	6.8	14.43
Net Income, 5 Yr. CAGR %	29.52	7.87	16.86	7.02	14.74
Normalized Net Income, 5 Yr. CAGR %	26.8	6.1	15.66	9.43	12.39
Diluted EPS Before Extra, 5 Yr. CAGR %	28.55	7.19	17.15	-0.05	7.68
Accounts Receivable, 5 Yr. CAGR %	7.74	14.38	3.06	8.34	7.41
Inventory, 5 Yr. CAGR %	27.59	25.31	79.57	55.25	48.8
Net Property, Plant and Equip., 5 Yr. CAGR %	1.83	3.59	6.62	6.15	12.47
Total Assets, 5 Yr. CAGR %	14.49	12.33	41.57	40.4	34.79
Tangible Book Value, 5 Yr. CAGR %	13.45	11.19	15.27	13.63	10.79
Common Equity, 5 Yr. CAGR %	15	12.59	46.85	44.58	39.07
Cash From Operations, 5 Yr. CAGR %	31.68	-71.82	8.05	13.73	12.99
Capital Expenditures, 5 Yr. CAGR %	34.98	39.55	21.47	7.45	4.46
Levered Free Cash Flow, 5 Yr. CAGR %	77.14	-12.79	63.58	33.14	-15.28
Unlevered Free Cash Flow, 5 Yr. CAGR %	66.67	-13.94	61.12	34.06	-10.85